Véronique Dubois

Author PubWeight™ 21.14‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Extended-spectrum beta-lactamase-producing Enterobacteriaceae in community and private health care centers. Antimicrob Agents Chemother 2003 1.33
2 Type II topoisomerase quinolone resistance-determining regions of Aeromonas caviae, A. hydrophila, and A. sobria complexes and mutations associated with quinolone resistance. Antimicrob Agents Chemother 2002 1.11
3 Decreased susceptibility to cefepime in a clinical strain of Escherichia coli related to plasmid- and integron-encoded OXA-30 beta-lactamase. Antimicrob Agents Chemother 2003 1.08
4 Clinical and molecular analysis of extended-spectrum {beta}-lactamase-producing enterobacteria in the community setting. J Clin Microbiol 2005 0.94
5 Discrepancy between uptake and intracellular activity of moxifloxacin in a Staphylococcus aureus-human THP-1 monocytic cell model. Antimicrob Agents Chemother 2002 0.94
6 Expression and spatial heterogeneity of dipeptidyl peptidases in endothelial cells of conduct vessels and capillaries. Biol Chem 2011 0.93
7 Dipeptidyl peptidase 8/9-like activity in human leukocytes. J Leukoc Biol 2007 0.91
8 Occurrence of Listeria spp. in effluents of French urban wastewater treatment plants. Appl Environ Microbiol 2005 0.89
9 Rapid identification of Listeria species by using restriction fragment length polymorphism of PCR-amplified 23S rRNA gene fragments. Appl Environ Microbiol 2003 0.89
10 Inhibition of lethal endotoxin shock with an L-pyridylalanine containing metalloproteinase inhibitor selected by high-throughput screening of a new peptide library. Comb Chem High Throughput Screen 2006 0.88
11 Extended-spectrum-beta-lactamase-producing Enterobacteriaceae strains in various types of private health care centers. Antimicrob Agents Chemother 2007 0.86
12 Evaluation of the Osiris expert system for identification of beta-lactam phenotypes in isolates of Pseudomonas aeruginosa. J Clin Microbiol 2003 0.85
13 Inhibitors of dipeptidyl peptidase 8 and dipeptidyl peptidase 9. Part 2: isoindoline containing inhibitors. Bioorg Med Chem Lett 2008 0.83
14 Inhibitors of dipeptidyl peptidase 8 and dipeptidyl peptidase 9. Part 1: identification of dipeptide derived leads. Bioorg Med Chem Lett 2008 0.82
15 Activity of linezolid in an in vitro pharmacokinetic-pharmacodynamic model using different dosages and Staphylococcus aureus and Enterococcus faecalis strains with and without a hypermutator phenotype. Antimicrob Agents Chemother 2010 0.82
16 Factors compromising the activity of moxifloxacin against intracellular Staphylococcus aureus. J Antimicrob Chemother 2007 0.81
17 Cross-infection due to imipenem-resistant Bacteroides fragilis associated with a totally implantable venous port. J Clin Microbiol 2002 0.81
18 Duplication of the chromosomal blaSHV-11 gene in a clinical hypermutable strain of Klebsiella pneumoniae. Microbiology 2010 0.79
19 Contrasting effects of human THP-1 cell differentiation on levofloxacin and moxifloxacin intracellular accumulation and activity against Staphylococcus aureus and Listeria monocytogenes. J Antimicrob Chemother 2008 0.79
20 Severe community-acquired Enterobacter pneumonia: a plea for greater awareness of the concept of health-care-associated pneumonia. BMC Infect Dis 2011 0.79
21 TEM-80, a novel inhibitor-resistant beta-lactamase in a clinical isolate of Enterobacter cloacae. Antimicrob Agents Chemother 2002 0.78
22 Reverse aggregate nucleation induced by acids in liquid-liquid extraction processes. Phys Chem Chem Phys 2014 0.78
23 Factors influencing the intracellular activity of fluoroquinolones: a study using levofloxacin in a Staphylococcus aureus THP-1 monocyte model. J Antimicrob Chemother 2006 0.77
24 TEM-21 extended-spectrum beta-lactamase in a clinical isolate of Alcaligenes faecalis from a nursing home. J Antimicrob Chemother 2005 0.76